Loading...
NYSE: ABT
Abbott Laboratories
Healthcare · Medical - Devices
●S&P 500 since 1957
Market Cap
$188.50B
52w High
$139.06
52w Low
$105.27
P/E
29.05
Volume
8.24M
Outstanding Shares
1.74B
Company profile
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.
CEORobert Ford
SectorHealthcare
IndustryMedical - Devices
Employees114,000
IPO dateMar 17, 1980
Valuation
Forward P/E—
EV/EBITDA19.51
Enterprise value$225.43B
Stock splits
Jan 2, 20135000:2399
May 3, 20042500:2339
Jun 1, 19982:1
Jun 1, 19922:1
Jun 1, 19902:1
Jun 2, 19862:1
Jun 1, 19812:1
May 23, 19782:1
Profitability & growth
Revenue growth4.42%
Gross margin55.51%▲9.20%vs FY2024
Operating margin18.16%▲11.59%vs FY2024
ROE12.51%▼55.49%vs FY2024
Analyst consensus
RatingBuy
Target price$137.67▲26.91%
29
Buy
10
Hold
0
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
Apr 15, 2026
View
EPS
Actual vs estimate by quarter
Q2FY25
ActualEst.
$1.26
$1.26
Q3FY25
ActualEst.
$1.30
$1.30
Q4FY25
ActualEst.
$1.50
$1.50
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q2FY25
ActualEst.
$11.14B
$11.09B
Q3FY25
ActualEst.
$11.37B
$11.39B
Q4FY25
ActualEst.
$11.46B
$11.8B
Q1FY26
Next Est.
—